Last reviewed · How we verify
NCT05131360: REDUCE
Reducing Daily Stress Among Sexual and Gender Minorities
NA trial testing Introduction Only in Social Discrimination in 80 participants. Status unknown.
30 March 2022
Quick facts
| Lead sponsor | New York University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 80 |
| Start date | 1 January 2021 |
| Primary completion | 30 March 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Introduction Only
- Purpose Only
- Connection Only
- Connection and Purpose
- Awareness Only
- Awareness and Purpose
- Awareness, Purpose, and Connection
- Awareness and Connection
Conditions studied
- Social Discrimination — all drugs for Social Discrimination →
- Sexual and Gender Minorities — all drugs for Sexual and Gender Minorities →
- Mindfulness — all drugs for Mindfulness →
Sponsor
New York University
Who can join
Adults 18 to 29, any sex, with Social Discrimination or Sexual and Gender Minorities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to identify which mindfulness technique, or combination of mindfulness techniques, is most effective at mediating or eliminating stress in emerging adults who are sexual and gender as well as racial or ethnic minorities. Participants will be randomly assigned to one of eight conditions that are composed of the mindfulness techniques of Awareness, Purpose, and Connection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Mindfulness-Based Intervention to Alleviate Stress From Discrimination Among Young Sexual and Gender Minorities of Color: Protocol for a Pilot Optimization Trial.
Cook SH, Wood EP, Mirin N, Bandel M, et al · · 2022 · cited 3× · PMID 34928237 · DOI 10.2196/35593
Verify or expand the search:
- PubMed search for NCT05131360
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other New York University trials
Trials by the same sponsor.
- NCT07526246 — Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect · NA · not yet recruiting
- NCT07519941 — Promoting Change in Practice for Respiratory Failure · NA · not yet recruiting
- NCT07071753 — Optimizing Online Purchasing of Fruits, Vegetables, and Legumes for Low-Income Families · NA · not yet recruiting
- NCT07530900 — Prediction of Visual Feedback Effects on Speech Motor Adaptation in Healthy Adults · NA · not yet recruiting
- NCT07278934 — Testing the Impact of Family-Based Intervention to Improve Developmental and Health Outcomes for Female Adolescents · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05131360 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York University
- Last refreshed: 23 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05131360.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing